The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer

Supplementation of BCAA found to reduce the risk of developing liver cancer, but the affect of BCAA on existing liver cancer is unknown.

The participants (post curative intent surgery) will be supplemented with either BCAA/non-BCAA-enriched protein supplement. The intervantion will go on for 2 years or until a new liver tumor is found.

Inclusion Criteria:

• diagnosed primary liver cancer
• viral or Nonalcoholic Steatohepatitis Cirrhosis
• Cirrhosis rated Child-Pugh A
• liver cancer rated Barcelona Clinic Liver Cancer (BCLC) A

Exclusion Criteria:

• Age (over 65)
• liver condition rated Child-Pugh B/C
• GI/Absorption issues
• patients given a treatment before surgery